← back to search

Chun‐Li Zhang

Center for Neuroscience and Regenerative Medicine · US
Area of research
Molecular Biology · Developmental Neuroscience
Research interest
Research interests include Neurogenesis and neuroplasticity mechanisms, Pluripotent Stem Cells Research, MicroRNA in disease regulation, and Epigenetics and DNA Methylation.
h-index
38
citations
8,611
works
79
NIH funding
primary concept
Biology
email

Recent publications

Skin-derived α-synuclein strains from PD, DLB, and MSA induce distinct intracellular pathology and neurodegeneration
Journal of Biological Chemistry 2026cited by 1position: contributordoi
Phosphorylation and DNA damage resolution coordinate SOX2-mediated reprogramming in vivo.
2026cited by 0position: contributordoi
Dysregulated nuclear Lamin B1 in DYT1 dystonia thickens nuclear lamina and disrupts 14-3-3 proteins.
2026cited by 0position: contributordoi
Atto 643 Carboxy Selectively Labels Astrocytes with Minimal Oligodendrocyte Cross-Reactivity
2026cited by 0position: contributordoi
In vivo reprogramming of NG2 glia improves bladder function after spinal cord injury
iScience 2026cited by 0position: contributordoi
GADD45G operates as a pathological sensor orchestrating reactive gliosis and neurodegeneration.
2025cited by 3position: contributordoi
Phosphorylation and DNA Damage Resolution Coordinate SOX2-Mediated Reprogramming in vivo
2025cited by 1position: contributordoi
Unbiased Quantification of Persistent Postural and Motor Deficits Following Spinal Cord Injury in Mice
2025cited by 1position: contributordoi
in vivo Reprogramming of NG2 Glia Improves Bladder Function After Spinal Cord Injury
2025cited by 0position: contributordoi
Dysregulated nuclear Lamin B1 in DYT1 dystonia thickens the nuclear lamina and disrupts 14-3-3 proteins
2025cited by 0position: contributordoi
The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury.
2025cited by 0position: contributordoi
Distinct alpha-synuclein strains derived from Parkinson’s disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model
2025cited by 0position: contributordoi
Simple and highly specific targeting of resident microglia with adeno-associated virus.
2024cited by 18position: contributordoi
Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease.
2024cited by 8position: contributordoi
NG2 glia reprogramming induces robust axonal regeneration after spinal cord injury.
2024cited by 4position: contributordoi
MAP4K inhibition as a potential therapy for amyotrophic lateral sclerosis.
2024cited by 4position: contributordoi
In vivo cell fate reprogramming for spinal cord repair.
2023cited by 8position: contributordoi
Simple and Highly Specific Targeting of Resident Microglia with Adeno-Associated Virus
2023cited by 0position: contributordoi
NG2 Glia Reprogramming Induces Robust Axonal Regeneration After Spinal Cord Injury
2023cited by 0position: contributordoi
Chemical screens in aging-relevant human motor neurons identify MAP4Ks as therapeutic targets for amyotrophic lateral sclerosis
2023cited by 0position: contributordoi
Resolution doubling in light-sheet microscopy via oblique plane structured illumination.
2022cited by 54position: contributordoi
In vivo glia-to-neuron conversion: pitfalls and solutions.
2022cited by 26position: contributordoi
NEK6 is an injury-responsive kinase cooperating with STAT3 in regulation of reactive astrogliosis.
2022cited by 12position: contributordoi
Reply to In vivo confusion over in vivo conversion.
2022cited by 10position: contributordoi
Resolution doubling in light-sheet microscopy via oblique plane structured illumination
2022cited by 5position: contributordoi
Revisiting astrocyte to neuron conversion with lineage tracing in vivo.
2021cited by 258position: contributordoi
Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia.
2021cited by 36position: contributordoi
Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease.
2020cited by 20position: contributordoi
Therapeutic Nanomaterials for Neurological Diseases and Cancer Therapy
Journal of Nanomaterials 2020cited by 13position: contributordoi
Rapid and efficient <i>in vivo</i> astrocyte-to-neuron conversion with regional identity and connectivity?
2020cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 32 papers (2019–2026) · 3 papers (2021–2024)Shu G. Chen · Jiangxi University of Traditional Chinese Medicine2 papers (2025–2026) · 2 papers (2025–2026)Jonathan R. Friedman · National Heart Lung and Blood Institute2 papers (2022–2022)Jacques Wadiche · Amyotrophic Lateral Sclerosis Association2 papers (2025–2026)Anupam Raina · Bangalore University2 papers (2025–2026)Baojin Ding · Louisiana State University2 papers (2025–2026)Xiaohui Yan · University of Alabama at Birmingham2 papers (2025–2026)Jose Carlos Gonzalez · University of Alabama at Birmingham2 papers (2025–2026) · 1 papers (2015–2015)Xiaoling Zhong · Center for Neuroscience and Regenerative Medicine1 papers (2017–2017)Derek K. Smith · University of Iowa1 papers (2017–2017)Marius Wernig · Stanford University1 papers (2015–2015)Jiahong Sun · University of Copenhagen1 papers (2017–2017)Chunhai Chen · The University of Texas Southwestern Medical Center1 papers (2017–2017)Yuqing Li · Anhui Medical University1 papers (2026–2026)Gong Chen · Guangdong Pharmaceutical University1 papers (2015–2015)Wenjiao Tai · Southwestern Medical Center1 papers (2017–2017)Lei-Lei Wang · The University of Texas Southwestern Medical Center1 papers (2017–2017)